LIGAND PHARMACEUTICALS I's ticker is and the CUSIP is 53220KAC2. A total of 1 filers reported holding LIGAND PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $6,276,000 | -69.7% | 4,330,000 | -74.7% | 0.09% | -70.0% |
| Q1 2015 | $20,741,000 | +11.1% | 17,107,000 | -10.0% | 0.30% | +9.5% |
| Q4 2014 | $18,662,000 | +79.1% | 19,016,000 | +72.9% | 0.27% | +70.2% |
| Q3 2014 | $10,420,000 | +55.0% | 11,000,000 | +57.1% | 0.16% | +61.0% |
| Q2 2014 | $6,724,000 | – | 7,000,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT CAPITAL MANAGEMENT /DE/ | 4,330,000 | $6,276,000 | 0.09% |